Condition: Autosomal Dominant RYR1-Related Myopathy · Sponsor: RyCarma Therapeutics, Inc.
This study is testing a medicine called surlorian in adults who have a genetic muscle condition known as autosomal dominant RYR1-related myopathy (RYR1-RM). The goal is to find out whether surlorian improves muscle weakness, and whether it is safe and well tolerated.
This description comes directly from the study's public registry record.
Patrick Round · 888-209-5458 · clinicaltrials@rycarma.com
Always discuss trial participation with your own doctor first.
| AP-HM- Hôpital de La Timone | Marseille, Bouches-du-Rhône, France | Not Yet Recruiting |
| Institut de Myologie - Hôpital de La Pitié-Salpétrière | Paris, France | Not Yet Recruiting |
| Universitätsklinikum Ulm | Ulm, Baden-Wurttemberg, Germany | Not Yet Recruiting |
| Charité - Campus Berlin Buch | Berlin, State of Berlin, Germany | Recruiting |
| Radboud Universitair Medisch Centrum | Nijmegen, Gelderland, Netherlands | Not Yet Recruiting |
| Hospital Universitario Vall d'Hebron - PPDS | Barcelona, Barcelona, Spain | Not Yet Recruiting |
| Hospital Universitario de Donostia | San Sebastián, Guipúzcoa, Spain | Not Yet Recruiting |
| The Robert Jones and Agnes Hunt Orthopaedic Hospital | Oswestry, Shropshire, United Kingdom | Not Yet Recruiting |
| University College Hospital - PPDS | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07560020